MassDevice.com +5 | The top 5 medtech stories for November 21, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Zimmer Biomet readies $1B tenders for senior debt Zimmer Biomet said today that it plans to float tender offers for some $1.1 billion worth of senior notes. The tenders are aimed at lowering the debt load it took on when Zimmer merged with Biomet last year. The Warsaw, Ind.-based orthopedics giant said it plans to buy and cancel its 5.75% senior notes due 2039, its 4.45% senior notes due 2045, its 4.25% senior notes due 2035, its 3.55% senior notes due 2025 and its 4.625% senior notes due 2019. The actual yields are slated to be determined Dec. 6, with a settlement date of Dec. 13, Zimmer Biomet said. Read more 4. NeuroStar launches real-world registry for TMS therapy in depression Transcranial magnetic stimulation device developer NeuroStar said today it launched a real-world registry for patients with depression treated with TMS therapy, touting it as the largest registry of its kind to date. The registry looks to collect and analyze data from over 6,000 patients with major depressive disorder who have been treated with NeuroStar Advanced Therapy to better understand out...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news